Follistatin-like protein 1 (FSTL-1) possesses several newly identified roles in mammalian biology, including interleukin (IL)-17-driven inflammation, though the mechanism underlying FSTL-1 influence on IL-17-mediated cytokine production is unknown. Using parallel in vitro bone marrow stromal cell models of FSTL-1 suppression, we employed unbiased microarray analysis to identify FSTL-1-regulated genes and pathways that could influence IL-17-dependent production of IL-6 and granulocyte colony-stimulating factor. We discovered that FSTL-1 modulates Il17rc gene expression. Specifically, FSTL-1 was necessary for Il17rc gene transcription, IL-17RC surface protein expression and IL-17-dependent cytokine production. This work identifies a mechanism by which FSTL-1 influences IL-17-driven inflammatory signaling in vitro and reveals a novel function for FSTL-1, as a modulator of gene expression. Thus enhanced understanding of the interplay between FSTL-1 and IL-17-mediated inflammation may provide insight into potential therapeutic targets of IL-17-mediated diseases and warrants ongoing study of in vivo models and clinical scenarios of FSTL-1-influenced diseases.
Follistatin-like protein 1 (FSTL-1) is a 306 amino-acid glycoprotein belonging to the SPARC/BM-40/osteonectin family that was originally cloned from the osteoblast cell line MC3T3-E1 as a transforming growth factor-β-inducible molecule. 1 Murine and human FSTL-1 share 91% amino-acid sequence homology, with five conserved domains: the eponymous follistatin-like domain, a Kazal serine protease domain, two EF-hand calcium-binding domains and a von Willebrand domain, though the functionality of these domains remain unclear. FSTL-1 has been identified in both secreted and intracellular compartments, suggesting differential cell trafficking regulation. Highly expressed in mammalian cells of mesenchymal lineage, several studies have implicated FSTL-1 with functions in a myriad of settings, including embryonic development, cardiac and lung dysfunction and repair, as well as tumorigenesis and metastasis and inflammation. [2] [3] [4] [5] [6] [7] [8] [9] In vivo modeling has been limited as FSTL-1 germline knockout (KO) mice display a perinatal lethal phenotype associated with multiple lung, skeletal and urogenital defects. However, murine models have employed neutralizing antibodies, small-interfering RNA, adenoviralgene transfer, partial gene disruption (FSTL-1 hypomorphs) and FSTL-1 transgenic models to begin characterizing in vivo functions of FSTL-1. 2, 3, 5, 6, 8, 10, 11 The role of FSTL-1 in inflammation and immunity remains unclear. We had shown that FSTL-1 expression positively correlated with degree of inflammation and joint disease severity in the collageninduced arthritis and Lyme arthritis models. 10, [12] [13] [14] Further, FSTL-1 facilitates cytokine production in response to a number of inflammatory signals. However, the specific mechanism(s) involved and cell populations of significance are actively being explored. For example, we have previously shown that, in macrophages/monocytes, FSTL-1 mediates NLRP3-inflammasome activation. 15 We have also observed that interleukin (IL)-17A in cooperation with tumor necrosis factor-α (TNFα) acts on bone marrow stromal cells (BMSCs) in an FSTL-1-dependent manner to induce IL-6 and monocyte chemotactic protein-1 production, 13 suggesting that novel mechanisms may be involved in FSTL-1-mediated inflammatory pathways.
IL-17, the eponymous cytokine produced by T helper type 17 (Th17) cells, signals via the IL-17 receptor complex. IL-17-mediated immune responses are central to both host defense against fungal and bacterial infection as well as autoimmune diseases, including ankylosing spondylitis, psoariasis and psoariatic arthritis. [16] [17] [18] [19] [20] [21] [22] [23] [24] IL-17 is not a potent mediator of inflammatory signaling in its own right but signals potently with a variety of other stimuli, including TNFα, fibroblast growth factor receptor and interferon-γ. 25 BMSCs represent a unique source of multipotent cells important for bone and joint homeostasis. They are also critically important for immune regulation and the host inflammatory response, in part through the IL-17 signaling axis. [26] [27] [28] Though FSTL-1 participates in several biological and inflammatory processes, the interaction between FSTL-1 and IL-17 signaling in BMSCs remains unknown. We sought to explore the interaction of FSTL-1 and IL-17-mediated inflammatory signaling in vitro in order to identify pathways that could be potential targets for therapeutic intervention and further investigation.
We first validated that FSTL-1 mediates IL-17A/TNFα-induced cytokine production using parallel strategies of FSTL-1 suppression in two in vitro BMSC systems. We then employed microarray analysis of these systems to identify candidate FSTL-1-influenced gene targets. Unexpectedly, we found that the IL-17 receptor C (IL-17RC), an essential subunit of the heterodimeric IL-17 receptor complex, was upregulated by FSTL-1. FSTL-1 KO cells were refractory to IL-17 signaling. Ectopic Il17rc expression via plasmid transfection rescued IL-17-stimulated cytokine production in the FSTL-1 KO cells. Further, plasmid Fstl1 transfection also rescued Il17rc gene expression and concomitant IL-17A-stimulated cytokine production. Mechanistically, FSTL-1-dependent Il17rc transcript abundance was due to de novo gene transcription and not mRNA stability, identifying for the first time a role for FSTL-1 in transcriptional regulation. Together, these studies confirm that FSTL-1 regulation of IL-17RC is a novel mechanism by which FSTL-1 modulates IL-17-stimulated cytokine production and a potential target for therapeutic intervention in IL-17-mediated diseases.
RESULTS

FSTL-1 suppression by short hairpin RNA (shRNA) reduces IL-17/TNFα-mediated cytokine production
To examine the role of FSTL-1 in BMSCs, we targeted Fstl1 mRNA expression using shRNA in the ST2 BMSC line following IL-17A/TNFα stimulation, as previously described. 13 Using this approach, we observed reduced Fstl1 mRNA abundance with or without IL-17A stimulation. Additionally, we found that IL-17A stimulation increased Fstl1 mRNA, suggesting that FSTL-1 was, at least in part, inducible by the IL-17 receptor signaling axis ( Figure 1a ). Knockdown with shRNA caused a significant reduction in secreted FSTL-1 protein both at baseline and following IL-17A stimulation ( Figure 1b ). To assess the effect of Fstl1 mRNA suppression on IL-17A-driven cytokine production, we evaluated the IL-17A-dependent cytokines Csf3/granulocyte colony-stimulating factor (G-CSF) and Il6/IL-6. Again, we observed that IL-17Astimulated Csf3/G-CSF was reduced in ST2 cells transfected with shRNA targeting the Fstl1 mRNA compared with control shRNA (Figures 1c and d) . Additionally, IL-17A-stimulated Il6/IL-6 production was substantially reduced in the FSTL-1 knockdown ST2 cells compared with control shRNA (Figures 1e and f) .
FSTL-1 suppression by gene deletion reduces IL-17/TNFα-mediated cytokine production
To further validate the effect of FSTL-1 in IL-17A/TNFα-driven cytokine production, we employed a parallel approach to attenuate FSTL-1 production in primary BMSCs. As previously described, 29 BMSCs from FSTL-1 KO embryonic mice had markedly reduced 
Microarray and gene expression analysis of the role of FSTL-1 in IL-17 signaling
To evaluate the potential pathways and gene targets underlying these FSTL-1-mediated events, we used an unbiased approach to evaluate gene expression by Affymetrix microarray. We assessed gene expression in ST2 cells and primary BMSCs, comparing control (WT) cells in which FSTL-1 was attenuated (ST2 shFSTL-1 or FSTL-1 KO, respectively) under baseline conditions and following stimulation with IL-17A/TNFα. We reasoned that bona fide candidate targets of FSTL-1-mediated IL-17A cytokine production would be differentially regulated in both the ST2 cell system and primary BMSCs under both conditions. To determine FSTL-1-regulated target genes independent of IL-17A stimulation, we identified transcripts upregulated ( Figure 3a ) or downregulated (Figure 3b ) under unstimulated and IL-17A/TNFα-stimulated conditions. Validating this workflow construct, Fstl1 was downregulated in ST2 cells under unstimulated (4.99-fold, P = 0.018) and IL-17A-stimulated (3.1-fold, P = 0.0095) conditions. Fstl1 was also downregulated in unstimulated (17.99-fold, P = 0.033) and stimulated (23.29-fold, P = 0.021) BMSCs, as expected. Indeed, 46 genes were upregulated ( Figure 3a ) and 23 genes were downregulated ( Figure 3b ) in this data set. Notably, we observed that Il17rc expression was downregulated in the ST2 unstimulated (1.1-fold, P = 0.034) and IL-17A-stimulated (1.34-fold, P = 0.0086) system as well as in the primary BMSC unstimulated (2.34-fold, P = 0.0057) and stimulated (2.39-fold, P = 0.0336) system. These data suggest that Il17rc expression may be a significant mediator of FSTL-1-dependent IL-17A cytokine regulation.
FSTL-1 attenuation is associated with reduced IL-17RC mRNA and protein expression
To verify the microarray finding that Il17rc is decreased in an FSTL-1dependent manner, we assessed its expression by quantitative reverse transcriptase-PCR for this transcript in both ST2 cells ( Figure 4a ) and primary BMSCs (Figure 4b ). These results indeed confirmed that Il17rc transcript was downregulated in the absence of FSTL-1. We then examined whether the decrease in transcript abundance was associated with reduced surface expression of IL-17RC protein by fluorescenceactivated cell sorter (FACS). A significantly higher percentage of WT cells expressed the IL-17RC protein compared with FSTL-1 KO cells ( Figure 4c ). Additionally, WT cells had a significantly greater mean fluorescence intensity compared with FSTL-1 KO BMSCs (Figures 4d and e ). Together, these data demonstrate that attenuation of FSTL-1 results in reduced Il17rc transcription and IL-17RC protein surface expression.
Ectopic Il17rc expression restores IL-17-dependent signaling in FSTL-1 KO cells
Having confirmed that IL-17RC was decreased in an FSTL-1dependent manner, we next sought to determine whether complementation with IL-17RC could rescue this effect. Accordingly, FSTL-1 KO BMSCs were transfected with a plasmid expressing murine Il17rc. This approach yielded increased Il17rc (Figure 5a ), and transfection of Il17rc partially rescued Il6 ( Figure 5b ) and Csf3 (Figure 5c ) production following IL-17A/TNFα stimulation in FSTL-1 BMSCs at or above the level of WT control-transfected cells. These data demonstrate that IL-17RC complementation in the FSTL-1 KO BMSCs is capable of partial rescue of IL-17A-stimulated cytokine suppression.
Ectopic Fstl1 expression rescues Il17rc expression and cytokine production in FSTL-1 KO cells
To investigate the relationship between FSTL-1 and IL-17RC regulation, we transfected FSTL-1 KO BMSCs with Fstl1 treated with or without IL-17A/TNFα stimulation ( Figure 6a ). Indeed, Fstl1 transfection significantly increased Il17rc transcript abundance (Figure 6b ), confirming a causal relationship between Fstl1 expression and Il17rc modulation. Moreover, Fstl1 complementation conferred increased production of Csf3 and Il6 (Figures 6c and d) upon stimulation, confirming that FSTL-1-regulated IL-17RC expression is sufficient to rescue IL-17-stimulated cytokine production.
Fstl1 influences Il17rc transcript abundance via transcriptional regulation
To better understand the mechanism by which FSTL-1 influences mRNA transcript abundance and subsequent protein surface expression, we stimulated WT and FSTL-1 KO BMSCs under conditions that inhibit new RNA synthesis (ActinomycinD) and separately using a nascent RNA-labeling approach. To assess whether Fstl1 regulates mRNA stability of Il17rc, we incubated WT and FSTL-1 KO cells with 5 μg ml − 1 ActinomycinD, a potent inhibitor of gene transcription, followed by RNA isolation at various time points (Figures 7a and b ). Before ActinomycinD treatment and all subsequent time points, there was a reduction of Fstl1 and Il17rc mRNA in FSTL-1 KO BMSCs. However, the rate of decay of Il17rc transcript was similar for both WT and FSTL-1 KO BMSCs (Figure 7c ), suggesting that the half-life of Il17rc transcript abundance was not FSTL-1 dependent.
To assess whether FSTL-1 regulated de novo gene transcription, adherent WT and FSTL-1 KO cells were labeled with 5-ethynyl uridine, which incorporates only into newly synthesized (nascent) RNA. We then examined nascent RNA at various time points postlabeling (Figures 7d-f ). This approach revealed that Hprt, Fstl1 and Il17rc transcripts were actively synthesized in BMSCs within 6 h showing similar nascent Hprt transcription between genotypes. However, FSTL-1 KO cells had decreased nascent Fstl1 and Il17rc mRNA identifying that newly synthesized l17rc transcripts were reduced in the absence of FSTL-1. Together, these studies suggest that FSTL-1 influences Il17rc transcript abundance by regulating gene transcription but not RNA stability.
Fstl1 expression correlates with Il17rc expression in the CD45-negative bone marrow population
To evaluate whether these findings in vitro were also observed in vivo, we sought to evaluate Fstl1 and Il17rc transcription in a BMSC population. We harvested bone marrow cells from femur flushes of WT C57Bl//6 mice and FSTL-1 Hypomorphic mice. FACS-sorted CD45-negative cells (predominately BMSCs) ( Figure 8 ) underwent gene expression analysis for Fstl1, Il17rc and Il17ra (an IL-17 receptor complex herterodimeric partner of IL-17RC). In this heterogenous CD45-negative population, FSTL-1 Hypomorphs showed slightly 
DISCUSSION
FSTL-1 is a molecule of emerging biological importance with recent studies identifying a role in tissue repair and development, novel mechanisms of transcriptional regulation and inflammation and host defense. Although some of these pathways have begun to be defined, the role of FSTL-1 in IL-17-elicited gene production is unknown. Nonetheless, advances in understanding of IL-17/Th17-driven inflammation have provided targets for therapeutic intervention, including small-molecule inhibitors and monoclonal antibodies aimed at IL-17-driven host responses, including autoimmune joint disease and psoariasis. [30] [31] [32] [33] [34] Therefore, understanding the mechanism underlying the influence of FSTL-1 on IL-17 inflammatory responses may spur development of novel therapies aimed at this disease pathway.
Here we identified the intersection of FSTL-1 and IL-17 using BMSCs, a clinically relevant model system. Herein we report that in vitro FSTL-1 modulates IL-17-mediated cytokine production by regulating Il17rc gene expression. Indeed, FSTL-1 appears to be necessary and sufficient to regulate Il17rc expression and that complementation of IL-17RC rescues IL-17-driven cytokine production in the context of FSTL-1 deficiency.
This observation is the first to show that FSTL-1 regulates gene transcription, a cytokine receptor, opening a new avenue of investigation into the molecular mechanism by which FSTL-1 performs this function. Disco-interacting protein 2 homolog A functions as an FSTL-1 receptor in mediating FSTL-1-dependent Akt phosphorylation in endothelial cells, cardiomyocytes and a rat ischemic stroke model. 11, 35 Other studies have suggested that FSTL-1 mediates multiple damage-associated molecular pattern/pathogen-associated molecular pattern-stimulated inflammation pathways involving Toll-like receptor 4/CD14 and nuclear factor-κB perhaps via phosphorylating multiple intermediates. 36, 37 We have shown that FSTL-1 localizes to mitochondria in macrophages yielding increased NLRP3 inflammasome activation and IL-1β secretion. 15 FSTL-1 also has a critical role in organogenesis as a transforming growth factor-β-inducible factor interacting with bone morphogenetic protein signaling/Smad phosphorylation, as well as influencing cell cycling. 3, 8, 15, 29, 38, 39 It remains to be determined the common factors shared among these systems, as regulation of Il17rc gene expression fails to explain the diverse functions of FSTL-1 in mammalian biological systems. Conversely, none of the above pathways have been implicated in Il1rc gene regulation, suggesting that additional cellular functions of FSTL-1 have yet to be identified.
Strikingly, there is very little information regarding the molecular mechanisms regulating Il17rc gene transcription. The methylation status of Il17rc has been associated with macular degeneration in human studies, though the precise role of Il17rc epigenetic regulation in this disease remains an area of active investigation. 40, 41 Additionally, multiple transcription factor-binding sites have been identified within Il17rc exons, suggesting that several independent pathways may influence its expression. Furthermore, while IL-17RC is highly expressed in bone, joint, prostate, liver and lung, IL-17RC is selectively and minimally detected in the leukocyte compartment, suggesting that cell-specific expression is tightly regulated. [42] [43] [44] [45] [46] [47] Notably, several splice variants of Il17rc are expressed in a tissue-specific manner, and factors influencing their regulation are unknown. 47, 48 Thus further study of the FSTL-1 regulation is likely to yield enhanced understanding of pathways influencing in IL17RC expression and possibly function.
These studies are currently limited by the lack of knowledge regarding molecular interactions between FSTL-1 and transcription factors or epigenetic regulators capable of modulating Il17rc gene expression, and studies to identify these aspects are needed to inform the cellular function(s) of FSTL-1. Additionally, as our work examines in vitro mechanisms of FSTL-1/IL-17 interaction, further work exploring the role of FSTL-1 in in vivo IL-17/Th17 models of inflammation and clinical disease processes is warranted to clarify the significance of our findings. Although FSTL-1 is expressed in the heart, lung, neuron and bone among others tissues, the cell and tissue-specific expression of FSTL-1 and the relationship to complex inflammatory diseases has yet to be explored.
In summary, this study identified a new function for FSTL-1, gene transcription modulation. Specifically, FSTL-1-mediated Il17rc regulation is a mechanism by which FSTL-1 mediates IL-17-driven FSTL-1 modulates IL-17 inflammation via IL-17RC BT Campfield et al cytokine production in vitro in BMSCs. This discovery represents a significant advance in our understanding of IL-17 biology, and ongoing mechanistic investigation of FSTL-1 function in this pathway may prove valuable for the design of therapies aimed at modulating Th17/IL-17-driven diseases. Additionally, this work suggests that further FSTL-1-focused investigation into innate and adaptive immune responses may yield new therapeutic targets, as the precise function of FSTL-1 in different inflammatory processes remains elusive.
METHODS
BMSC culture
The murine ST2 BMSC line has been utilized extensively for the in vitro study of IL-17 signaling. 18, 49 Cells were stably transduced with murine FSTL1 shRNA or a control lentivirus shRNA (Santa Cruz Biotechnology, Dallas, TX, USA) according to the manufacturer's protocol and clonally selected, as previously described. 13 Primary BMSCs were isolated from FSTL-1 KO embryos as previously described. 29 Cells were cultured in Dulbecco's Modified Eagle Medium supplemented with heat-inactivated 10% fetal bovine serum (FBS) FSTL-1 modulates IL-17 inflammation via IL-17RC BT Campfield et al for ST2 cells and 15% FBS for BMSCs. In 12 wells, we plated 100 000 cells per well followed by stimulation with either 8 ng ml − 1 IL-17A (R&D 7956-ML, Minneapolis, MN, USA) and 2 ng ml − 1 TNFα (R&D 410-MT-010) or media alone in duplicate; for microarray studies, each group contained n = 3. Cells were then harvested for RNA at 6 h poststimulation or collection of supernatant 24 h poststimulation. Randomization was included in treatment design prior to each experiment. Each experiment depicted was performed at least two times to ensure reproducibility.
RNA and microarray analysis
Total RNA was isolated from cells using the RNeasy Kit (Qiagen, Germantown, MD, USA), and cDNA was synthesized using iScrip 8t (Bio-Rad, Hercules, CA, USA) according to the manufacturer's instructions. Gene expression was analyzed by quantitative PCR performed using primer/probe pairs for Hprt, Fstl1, Il6, Csf3 and Il17rc (Applied Biosystems, Carlsbad, CA, USA) in the C1000 Touch/CFX96 Real-Time System (Bio-Rad). RNA quality was verified using the 2100 Bioanalyzer (Agilent, Santa Clara, CA, USA) before undergoing microarray analysis performed on ST2 cells using Mouse WG8.0 and BMSCs using Mouse WG6 2.0 Expression Bead Chip (Affymetrix, Waltham, MA, USA) at the Genomics and Proteomics Core Laboratories, University of Pittsburgh. We defined differential expression as significant by setting threshold levels of ⩾ 1.1-fold change and Po0.05 by t-test with Bonferroni correction. Gene lists meeting these criteria were cross-analyzed for common FSTL-1-dependent differentially expressed genes.
Protein secretion analysis
Supernatant protein concentrations were determined for FSTL-1 by ELISA, as previously described, 13 and for IL-6 and G-CSF using the xMAP multiplex system (Millipore, Darmstadt, Germany) according to the manufacturer's instructions.
FACS analysis
WT and FSTL-1 KO cells were stained for IL-17RC surface expression using allophycocyanin (APC)-conjugated anti-IL-17RC (R&D FAB2270A) or APC-IgG control (R&D IC108A). Cells were trypsinized, washed in 0.5% FBS in phosphate-buffered saline, centrifuged at low speed, Fc blocked with CD16/32 and stained with APC-conjugated anti-mouse IL-17RC or APC-conjugated isotype control. Cells were sorted using an LSR II flow cytometer (BD Biosciences, Pittsburgh, PA, USA), and the data were analyzed using FlowJo software (TreeStar, Ashland, OR, USA). 
Il17rc and Fstl1 plasmid transfection
mRNA regulation studies
To assess mRNA stability, WT and FSTL-1 KO cells were incubated with 5 μg ml − 1 ActinomycinD, to inhibit gene transcription, followed by RNA isolation at various time points post-ActinomycinD treatment. At each time, untreated cells were used as a normalizing control to assess the rate of decay. Gene expression was assessed as described above.
To assess nascent mRNA systhesis, WT and FSTL-1 KO BMSCs were cultured for 18 h to allow adherence. Using the Click-iT Nascent RNA Capture Kit (ThermoFisher Scientific Cat. no. C10365), cells were labeled for various lengths of time (0, 1, 2, 4 and 6 h) with 150 μM 5-ethynyl uridine. Cells were harvested using TRIzol reagent and half of this volume was used to isolate total RNA, while the remainder was used as input for the nascent RNA capture, which was followed according to the manufacturer's protocol to recover the labeled, newly synthesized mRNA. Labeled mRNA underwent reverse transcription using iScript in addition to total cell RNA as described above. Nascent mRNA for each transcript was normalized to total Hprt for relative abundance analysis.
Bone marrow population analysis
C57Bl/6 and FSTL-1 Hypomorphic (on C57Bl/6 background) mice were housed in accordance with the approved University of Pittsburgh School of Medicine Institutional Animal Care and Use Committee protocol. 12 The bone marrow compartment of male and female WT and FSTL-1 Hypomorhic mice was isolated by femur flush protocol. 50 Isolated bone marrow cells were resuspended in sterile phosphate-buffered saline and counted using trypan blue stain and a hemocytometer. The cells were first blocked using anti-mouse CD16/CD32 (eBioscience, Waltham, MA, USA) and subsequently surfaced stained in the presence of anti-mouse CD45 antibody (clone 30-F11, BD Bioscience, Billerica, MA, USA). CD45-positive and CD45-negative cell populations were then sorted on a FACSAria via the FACSDiva software (Becton Dickinson, Franklin Lakes, NJ, USA) into phosphate-buffered saline. The sorted cell populations were pelleted and resuspended in RNA Lysis Buffer (Zymo Research). RNA was processed for gene expression analysis as previously described. These experiments were performed twice with n = 3 or n = 4 per group each time. Data shown include cells from all animals in the two experiments.
Statistical analysis
Investigators were not blinded to treatment but were blinded to individual per group during data analysis. All statistics were performed using GraphPad
